ZURA - Zura Bio Limited Class A Ordinary Shares

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.72 -0.04 (-1.08%)	---	---	---	-0.1 (-2.69%)	0.1 (2.76%)	0.01 (0.27%)	0.01 (0.27%)

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.17
Diluted EPS:: -0.17
Basic P/E:: -21.6471
Diluted P/E:: -21.6471
RSI(14) 1m:: 0.0
VWAP:: 3.68
RVol:: 0.3475

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	3.74 +0.18 (+5.06%)	Oct 15 15:56
1m	Price increase 1m	3.74 +0.12 (+3.31%)	Oct 15 15:56
1m	Price increase 1m	3.58 +0.04 (+1.13%)	Oct 15 11:21
1m	Price decrease 1m	3.54 -0.04 (-1.26%)	Oct 15 11:19
1m	Price decrease 1m	3.66 -0.04 (-1.08%)	Oct 15 10:50